Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene

NCT06435000 is registered in ClinicalTrials.gov with Splice Bio as lead sponsor.

NCT NCT06435000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene
Lead sponsor
Splice Bio
Phase
Observational
Overall status
Recruiting
Start date
March 29, 2024
Completion date
February 28, 2027
Enrollment
75 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

stargardt, stargardt disease, stargardt's disease, stgd1